
01 October 2026Event
Brussels HLS Day
The Future of Health Regulation 2026 – Pharma, MedTech & Data in Transition
From 15 January 2024, the Serious Fraud Office has been given new powers to compel the production of documents, and require attendance at interviews, at the pre-investigation stage for all cases. Previously, such powers only applied in international bribery and corruption cases. The SFO has welcomed these changes, saying that: “The use of these powers at the earliest possible stage usually results in high-quality targeted intelligence packages, which allow an investigation to advance more quickly”.
ECCTA removes the statutory cap on the powers of the Solicitors Regulation Authority (in England and Wales) and the Scottish Solicitors’ Discipline Tribunal to fine solicitors for disciplinary matters relating to economic crime. Legal services regulators have also been given a new regulatory objective requiring them to focus on promoting the prevention and detection of economic crime.
This document (and any information accessed through links in this document) is provided for information purposes only and does not constitute legal advice. Professional legal advice should be obtained before taking or refraining from any action as a result of the contents of this document.
If you have any questions, contact a member of the Regulatory and Investigatory powers team for assistance:

01 October 2026Event
The Future of Health Regulation 2026 – Pharma, MedTech & Data in Transition

22 July 2026 Publication
A summary of the Central Bank of Ireland's Markets Update No 12 of 2026 for regulated firms and other market participants

22 July 2026 Publication
On 30 June 2026, the FCA finalised the prudential rules for the new Cryptoasset regime

22 July 2026 Publication
On 30 June 2026, the FCA published a suite of policy statements as part of its Cryptoasset Roadmap

22 July 2026 Publication
PS26/13 sets out how FCA Handbook provisions apply to cryptoassets